Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | 21 | 0 | 3 | 0 | €3.64 | €11.04 | 203.363% |
| AbbVie Inc. | 22 | 0 | 4 | 0 | €153.08 | €175.11 | 14.392% |
| Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.17 | €28.06 | 84.976% |
| Zoetis Inc. A | 23 | 1 | 4 | 0 | €160.06 | €200.06 | 24.989% |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €100.25 | €184.92 | 84.459% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €60.00 | €79.55 | 32.591% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €287.50 | €297.31 | 3.413% |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | €55.00 | €85.64 | 55.715% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €130.90 | €140.60 | 7.413% |
| Pfizer Inc. | 29 | 4 | 1 | 0 | €26.35 | €40.66 | 54.306% |
| Johnson & Johnson | 33 | 1 | 2 | 0 | €142.26 | €196.36 | 38.029% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 5 | 0 | €903.60 | €958.32 | 6.055% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €137.45 | €236.30 | 71.916% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €409.55 | €409.07 | -0.118% |
| Biogen Inc. | 47 | 1 | 7 | 1 | €212.10 | €294.45 | 38.825% |
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | €708.70 | €771.54 | 8.867% |